LNCAROD is also highly expressed in bladder urothelial carcinoma and predicts unfavorable prognosis (Gao et al., 2019), suggesting an oncogenic role in cancer development. The gene discussed is LNCAROD; the disease is bladder transitional cell carcinoma.